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ABSTRACT 
Bladder cancer is among the most common cancers worldwide (4th in men). It is responsible for high patient morbidity 
and displays rapid recurrence and progression. Lack of sensitivity of gold standard techniques (white light cystoscopy, 
voided urine cytology) means many early treatable cases are missed. The result is a large number of advanced cases of 
bladder cancer which require extensive treatment and monitoring. For this reason, bladder cancer is the single most 
expensive cancer to treat on a per patient basis. In recent years, autofluorescence spectroscopy has begun to shed light 
into disease research. Of particular interest in cancer research are the fluorescent metabolic cofactors NADH and FAD. 
Early in tumour development, cancer cells often undergo a metabolic shift (the Warburg effect) resulting in increased 
NADH. The ratio of NADH to FAD (“redox ratio”) can therefore be used as an indicator of the metabolic status of cells. 
Redox ratio measurements have been used to differentiate between healthy and cancer breast cells and to monitor cellular 
responses to therapies. Here, we have demonstrated, using healthy and bladder cancer cell lines, a statistically significant 
difference in the redox ratio of bladder cancer cells, indicative of a metabolic shift. To do this we customised a standard 
flow cytometer to excite and record fluorescence specifically from NADH and FAD, along with a method for 
automatically calculating the redox ratio of individual cells within large populations. These results could inform the 
design of novel probes and screening systems for the early detection of bladder cancer.  
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INTRODUCTION 
Bladder cancer (BCa) is among the most common cancers worldwide, is responsible for significant patient morbidity and 
is a particular issue in aging populations1. It can be broadly split into two categories: muscle invasive bladder cancer 
(MIBC) and non-muscle invasive bladder cancer (NMIBC). NMIBC is by far the most common form of BCa but if left 
unchecked can progress to invasive phenotypes. Furthermore, over two-thirds of NMIBC instances will recur. This 
means it is imperative to monitor patients with the disease very closely after initial diagnosis and/or therapy. Follow-up 
surveillance of BCa is achieved using one or both of white light cystoscopy (WLC) and voided urine cytology (VUC). 
Unfortunately, WLC and VUC, although useful, suffer from relatively low sensitivity, especially for low grade, early 
stage tumours and CIS2. This results in sub-optimal patient surveillance and high levels of BCa recurrence and 
progression3. The high levels of recurrence and progression in BCa and the associated treatment and surveillance costs 
make BCa among the most expensive cancers to monitor and treat per patient4. For this reason, numerous attempts have 
been made to develop BCa detection techniques with improved sensitivity. Chief among these was the advent of 
photodynamic diagnosis (PDD), achieved by applied photosensitising dye (PS) into the bladder and utilising its 
preferential uptake by tumours as a guide for imaging modalities5. PDD shows selective benefits compared to WLC 
owing to its greatly improved sensitivity, however this comes at the cost of diminished specificity, high cost and 
increased patient lay-up time6, 7. VUC is an attractive tool for screening surveillance of bladder cancer owing to its non-
invasive nature, however its relative lack of sensitivity and the need for skilled pathologists to interpret results serve as 
considerable drawbacks. Many commercially available kits have been developed for urine analysis and bladder cancer 
detection8, including the NMP22 test, Urovysion and BTA STAT. Unfortunately, many large scale meta-analyses of 
these tests have found them to be no more effective than VUC for the detection and surveillance of BCa9, 10. It is evident 
that new avenues must therefore be sought for the early detection of BCa. Autofluorescence spectroscopy has enjoyed 
success in recent years as an imaging modality for detection of numerous cancers (bladder included)11-14. This is a 
technique which relies on the inherent fluorescence of cells and tissues to document changes in physiology, without the 
need for dyes. Two diagnostically relevant endogenous fluorophores are reduced Nicotinamide dinucleotide (NADH) 
and Flavin adenine dinucleotide (FAD), which can be observed to monitor metabolic changes in cells. Early in tumour 
progression, cancer cells often undergo a metabolic switch to favour energy production through aerobic glycolysis in 
place of oxidative phosphorylation (known as the Warburg effect15). The structure and function of the electron transport 
chain (ETC) - responsible for oxidative phosphorylation – with NADH as the principal electron donor means that ETC 
shutdown leads to the accumulation of NADH within cells which have undergone a “glycolytic switch”. The “optical 
redox ratio” (ORR) allows us to take advantage of the optical properties of NADH and the related electron acceptor FAD 
to detect ETC shutdown in cancerous cells. The ORR is calculated as [NADH]/[FAD], with cancer cells showing 
increased ORR compared to healthy controls. The accuracy of the ORR has previously been demonstrated in pre-
cancerous epithelia16, 17 suggesting its worth as a tool for sensitive monitoring of early stage and grade BCa. Our main 
aim was to compare the ORR of healthy and BCa cell lines using a customised flow cytometer, to inform potential VUC 
strategies based on cellular autofluorescence. Our hypothesis was that BCa cells would possess a significantly increased 
ORR compared to healthy controls owing to ETC shutdown and NADH accumulation.  
METHODS 
Cell culture 
HUC bladder urothelial cell line (Caltag Medsystems) and 5637 BCa cell line (ATCC) were grown to confluence in 
75cm2 culture flasks (Corning) with Dulbecco’s Modified Eagle Medium (Sigma-Aldrich) including 1% Penicillin-
Streptomycin and 10% Fetal Bovine Serum. Cells were prepared for study by trypsinising according to standard 
protocol. Cell suspension was passed through a 30µm filter into a FACS tube. Cells were suspended in PBS (1% FBS) at 
approximately 4 x 106/ml in all cases. All cell lines used, and the working environment, were certified Mycoplasma free. 
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Fluorescence Spectroscopy of biomarkers 
NADH and FAD were purchased as powders (Sigma-Aldrich) and prepared to 10µM solutions in sterile PBS to be 
studied using a ‘LAKK-M’ laser spectroscopy device (SPE-LAZMA, Moscow, Russia). A 5ml solution was added to a 
matte black cuvette (SPE-LAZMA, Moscow, Russia). Solutions of NADH and FAD were excited sequentially with UV 
(365nm) and Blue (450nm) sources to optimally excite the fluorophores. Data was visualised using custom-built 
software (SPE-LAZMA). 
 
Confocal microscopy 
“5637” BCa cells were grown in Petri dishes with coverslip thickness bottoms #1.5 (WillCoWells) in DMEM (10% FBS, 
1% Pen-Strep), until 75% confluent. Cells were stained with a 100nM solution of MitoTracker Red (Molecular Probes) 
for 45 minutes. A Carl Zeiss 710 confocal microscope was used. NADH was excited at 350nm and FAD was excited at 
488nm. Fluorescence was captured using a CCD camera with 450/20 and 530/20 bandpass filters to isolate NADH and 
FAD fluorescence, respectively. MitoTracker Red was excited at 579nm and detected at 599nm. A total of 50 cells were 
studied in this manner. The three excitation wavelengths were used sequentially and data stored for each frame. Images 
of cells captured using CCD were processed using ImageJ (imageJ.nih.gov). Images from all fluorophores were merged 
to overlap mitochondrial fluorescence and autofluorescence.  
 
Flow cytometry 
BD Fortessa flow cytometer (Becton Dickinson) was used. Both healthy and cancerous cells were passed through the 
system at “low” speed setting to set voltages and template population gates. Cell data was acquired at high speed from 
10,000 events. In-built blue laser (488nm) was used at a power setting of 162V to analyse forward scatter and signal 
width of events. All populations of cells were plotted logarithmically with respect to forward scatter and signal width. 
All samples were gated identically on forward scatter and signal width to remove dead and doublet cells. NADH and 
FAD were sequentially excited using UV laser (360nm) and blue laser (488nm), respectively. Excitation sources were 
kept as close to excitation maxima as possible for the molecules of interest (NADH Ex Max = 350nm; FAD Ex Max = 
450nm). UV laser was run at a power setting of 211V, blue laser was run at a power setting of 397V. The NADH-
specific signal was processed using a 450/50 bandpass filter (NADH Em Max = 450nm), and the FAD-specific signal 
was processed using a 530/30 bandpass filter (FAD Em Max 530nm). FCS data files containing all data were saved and 
transferred for analysis. Compensation was not required as all results were derived as ratios. Cell viability was 
determined following flow cytometry on both cell types in suspension using trypan blue and confirmed to be over 95% 
for all samples.  
 
Data analysis 
FCS data files were analysed using FCS Express Flow Cytometry Package. Bivariate dot plots were generated on a 
logarithmic scale based on forward scatter and signal width of each event. An inclusive elliptical gate was drawn 
between co-ordinates 3.8K, 68K and 113K, 154K. The percentage of cells gated in for each sample were as follows: 
HUC sample 1 – 85.9%; HUC sample 2 – 68.3%; HUC sample 3 – 72%; 5637 sample 1 – 89.3%; 5637 sample 2 – 
91.5%; 5637 sample 3 – 71.8%. Individual data on NADH and FAD data was exported from FCS Express, following 
gating, to Origin Pro 8 statistics software, to calculate means, medians, standard deviations, and standard errors. The 
average redox ratio was calculated for each population by dividing average NADH fluorescence across 400-500nm by 
average FAD fluorescence across 500-560nm to yield a real number between 0–10. Average redox ratios of whole 
populations of cells were analysed for significant differences using student’s t test.  
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RESULTS 
Fluorescence spectra of NADH and FAD 
NADH possesses fluorescence maximum at 490nm (Fig.2a). FAD has its maximum at 550nm (Fig.2a&b). NADH 
displays no fluorescence upon 450nm excitation (Fig.2b); however, there is a significant degree of FAD fluorescence 
when excited at 365nm (Fig.2a), which overlaps with NADH. 
 
Fig.1: Fluorescence spectroscopy of NADH and FAD solutions (black line and red line, respectively) using 365nm excitation (a) and 
450nm excitation (b) 
Confocal localisation of cellular autofluorescence 
Comparing cellular autofluorescence signals in Fig. 2 from NADH (Green image) and FAD (Purple image) over 
MitoTracker red signal (Red image) enables direct analysis of the localisation of autofluorescence. Figure 2 clearly 
shows that autofluorescence excited and recorded at the parameters used is arising from the mitochondria.  
 
 
Fig.2: Confocal microscopy images of cellular localization of MitoTracker Red (red), NADH (green) and FAD (purple) 
 
Creation of “redox overview” 
Using NADH and FAD values for each cell, we can plot the metabolic profile of a population of cells, charting 
increasing NADH on the x axis and increasing FAD on the y axis. Fig. 3 displays the redox overviews of HUC healthy 
controls (a) and “5637” BCa cells (b) showing replicable differences in the population distributions.  
Proc. of SPIE Vol. 9303  93030T-4
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 04/28/2015 Terms of Use: http://spiedl.org/terms
o
u-
Specrnen 001 HUC tics compensated
too
loo
-10
lOo
Specrnen 001 HOC 2 los compensated I
10'
e
103
loll
-10' I
Spec., en_001_11UC 3105 compensated
loo
loo
loo
-10'
-to' 10' 10 le 10° 40 . 10 io' le to'
Aie. Fluor 350-A Mesa Fluor 350-A
I specimen 001 5837 Ike compensated
m'
o
Isw.Nm 001 sosrzesmmpen.tlm I I soeanm ON 5637 ae. compensated I
o' +d
aó
wÌew35dÁ eon -eo' 'o2A1000e35ÚÁ
too
a
eo
to ApwKop3süÁ
0.6 -
0.5 -
0.4 -
0.2 -
0.1 -
0.0
Healthy
Sample
Cancer
 
 
 
Fig.3: Redox overviews of (a) healthy urothelial cells and (b) 5637 BCa cells, charting increased NADH in x and increased FAD in y 
Comparison of average redox ratios of bladder cancer cells and healthy controls 
Fig.4 displays the mean and SEM optical redox ratios of healthy (0.457+/-0.022) and cancer cells (0.588+/-0.018). The p 
value for these results, calculated using Student’s t test, was found to be <0.05, allowing us to reject the Null hypothesis.  
 
Fig.4: Comparison of the average redox ratios for three populations of healthy bladder and BCa cells, including SEM 
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DISCUSSION 
We hypothesised that BCa cells would possess a significantly increased ORR compared to healthy controls owing to 
their selective accumulation of NADH. Statistical analysis of autofluorescence data has shown a p<0.05, confirming that 
the increased ORR observed in BCa cells is statistically significant. This finding helps to improve our understanding of 
the metabolic capabilities of healthy and cancerous bladder cells. BCa is therefore in keeping with other cancers, such as 
breast cancer18 in that it undergoes a metabolic switch resulting in mitochondrial accumulation of NADH. Importantly, 
we were capable of observing this difference using a conventional flow cytometer with customised band pass filters. 
Flow cytometry has a number of useful applications in clinical cancer diagnosis19 including DNA image cytometry for 
BCa20. Flow cytometry as a clinical adjunct for BCa detection and monitoring is therefore an established procedure, 
confirming sufficient cell yield in voided urine of BCa patients for comprehensive analysis. This technique presents 
some advantages over microscopy for clinical cellular analysis as cells can be rapidly processed and analysed and 
fluorescence quantified automatically. Autofluorescence flow cytometry is a poorly studied field, however the necessary 
removal of autofluorescence signals from conventional flow results21 suggests it warrants further investigation in its own 
right. The idea of NADH and FAD monitoring using flow cytometry was first suggested in the 1980’s22, but to our 
knowledge, ours is the first demonstration of the clinical worth of autofluorescence flow cytometry in bladder cancer 
monitoring. Autofluorescence flow cytometry of voided urine may serve to augment the sensitivity of conventional 
diagnostic tests, providing a cheap and rapid technique to aid in screening programmes which are currently hampered by 
time and cost23. As demonstrated in this paper, the metabolic fluorophores NADH and FAD have defined excitation and 
emission parameters which allow their specification in flow setups. Rationing of NADH and FAD to create the ORR 
allows us to account for the spectral overlap in the fluorophores and also for size and granularity disparities in cells. The 
ORR is therefore a relatively reliable method for calculating the metabolic conditions of cells. The replicable differences 
in redox overview (NADH amplitude versus FAD amplitude) between healthy and cancer samples suggest diagnostic 
thresholding at this stage is a possibility. Diagnostic thresholding helps clinicians by giving automated diagnoses without 
the need for detailed interpretation, however this step would require validation from extensive patient studies. One of the 
major current limitations of flow cytometry to clinical applicability is the size and bulkiness of many benchtop analysers. 
Ongoing research is constantly reducing the size and complexity of flow cytometers and recently a mobile phone based 
single colour cytometer has been announced24. Size limitations of cytometry therefore may no longer be the issue they 
once were. Similarly, constant progress in laser diode development may help us overcome limitations with the relatively 
low quantum yield of endogenous fluorophores.  
CONCLUSION 
In this work we have demonstrated a statistically significant increase in the optical redox ratio (ORR) of bladder cancer 
cells compared to healthy cells, owing to selective mitochondrial accumulation of NADH in cancer cells which have 
undergone glycolytic switching. The application of the autofluorescence based flow cytometry method we have 
described could help to augment clinical work in voided urine cytology for diagnosis of bladder cancer.  
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